Finans Haberleri — Borsa ve Piyasa Gündemi

▼

—

Advertising Week Europe boss: humans still run the show in the age of AI

As Advertising Week Europe kicks off, the conversation isn’t about replacing human talent, but about recalibration,...

▼

—

Australia shares higher at close of trade; S&P/ASX 200 up 0.16%

▼

—

Palantir turns poisonous on the campaign trail

Donald Trump’s unpopular immigration crackdown has made links to the Peter Thiel-backed company a liability for...

▼

—

Apollo agrees biggest Japan deal in $3.7bn rescue of glassmaker NSG

Japanese manufacturer has struggled since swooping for UK rival Pilkington two decades ago

▼

—

Edinburgh Worldwide Investment Trust schedules tender offer Q&A

▼

—

Morgan Stanley cuts Teleperformance stock rating on weak growth outlook

▼

—

Hardide reports 50% revenue jump in first half of 2026

▼

—

PPHC joins Russell 2000 and 3000 indexes after Nasdaq IPO

▼

—

Japan shares higher at close of trade; Nikkei 225 up 1.56%

▼

—

YouGov non-executive director Shalini Govil-Pai steps down

▼

—

Japan’s SMFG explores possible takeover of Jefferies

Sumitomo Mitsui’s banking unit holds minority stake in US investment bank

▼

—

Tharisa secures $45m in enhanced trade finance facilities

▼

—

Goldman Sachs initiates Generate Biomedicines stock with buy rating on AI platform potential

▼

—

A billionaire is taking the UK’s Indian restaurants global

Prem Watsa of Fairfax Financial wants to expand the owner of Chutney Mary and Veeraswamy to the US, Canada and the Gulf

▼

—

Rothschild Redburn initiates Solventum stock with Sell rating

▼

—

Puig stock jumps 14% following confirmed merger talks with Estée Lauder

▼

—

Relmada Therapeutics stock initiated at Overweight by Piper Sandler

▼

—

B.Riley initiates Climb Bio stock with buy rating on kidney drug potential

▼

—

Vets will have to cap prescription fees at £21 and publish price lists, says competition regulator

The Competition and Markets Authority published the final reforms for the sector after opening an investigation in 2024.

▼

—

Piper Sandler initiates Generate Biomedicines stock at overweight

▼

—

Goldman Sachs initiates Smurfit Westrock stock with buy rating

▼

—

Citizens reiterates Ocular Therapeutix stock rating amid litigation

▼

—

Citizens reiterates GDS Holdings stock rating on AI demand outlook

▼

—

Citizens reiterates Hilton Grand Vacations stock rating on model update

▼

—

Citizens reiterates Acrivon Therapeutics stock rating on endometrial cancer trial progress

▼

—

Bellway shares fall over 8% after margin squeeze offsets revenue gains in H1 2026

▼

—

Companies will have to pay UK supplier invoices within 60 days or face fines

CBI praises legislation aimed at protecting small businesses for striking ‘the right balance’

▼

—

‘Crossroads’: Oil prices hold firm as markets sour on Trump’s peace talks

The price of oil held firm on Tuesday morning as markets faced a “crossroads” following the latest bait-and-switch from President Trump amid the crisis in the Middle East.

▼

—

Bank of London hit with £2m fine for ‘misleading’ watchdog

The Bank of London has been slapped with a hefty fine from the banking watchdog after “misleading” the regulator and “failing to act with integrity”.

▼

—

Silver Bow Mining plans NYSE American debut with $50 million IPO

▼

—

Britain on 'stagflation' alert as war in Middle East leaves manufacturers facing sharpest rise in costs since Black Wednesday in 1992

'Input prices' paid by manufacturers for supplies have risen at the sharpest rate since October 1992 - month after...

▼

—

Barclays expects Swiss franc strength despite SNB dovish stance

▼

—

USD/CAD: Barclays cuts Canadian dollar outlook on trade uncertainty

▼

—

SK Hynix to purchase $7.97 billion in EUV tools from ASML by 2027

▼

—

Scandal rocks Czech football on eve of Republic of Ireland World Cup play-off

Czech football has reportedly been rocked by the biggest match-fixing scandal in its history on the eve of the national team’s World Cup play-off with the Republic of Ireland.

▼

—

Bank of London fined over faked documents

Fintech, where Peter Mandelson and Harvey Schwartz were board members, is given £2mn penalty by Bank of England

▼

—

Apogee Therapeutics stock price target raised to $160 by Guggenheim on trial data

▼

—

Guggenheim reiterates Buy on Pyxis Oncology stock ahead of trial data

▼

—

NAO: The government’s new Financial Transaction Control Framework needs improvement

The National Audit Office’s new report assesses whether the government’s new Financial Transaction Control Framework...

▼

—

Wedbush initiates Nektar Therapeutics stock with neutral rating

▼

—

This must-book Kenya safari goes way beyond The Big Five

“Back in the 1990s when I was growing up here, it was bandit country.

▼

—

Jefferies says Tesla solar plans may pressure First Solar stock

▼

—

ASML stock: Morgan Stanley flags ’limited near-term upside’

▼

—

Thermo Fisher completes $8.9B acquisition of Clario

▼

—

Turn Therapeutics secures $25M loan facility from Avenue Capital

▼

—

SEC questions ratings issued by agency behind private credit boom

Egan-Jones has come under scrutiny for its ratings on thousands of private loans relied on by insurers

▼

—

Form DEF 14A GRAHAM HOLDINGS COMPANY For: 24 March

▼

—

Form 6K ReNew Energy Global PLC For: 24 March

▼

—

Earnings call transcript: Cheetah Mobile Q4 2025 reveals mixed results

▼

—

Bank backed by disgraced Labour grandee Peter Mandelson fined £2million for 'failing to act with integrity'

Bank of London and its parent group Oplyse Holdings were hit with the penalty after misleading regulators over its...

Finans Haberleri — Borsa ve Piyasa Gündemi | Pusula Yatırım